Dutasteride

Spécifications

164656-23-9Numéro CAS

638-758-5Numéro CE

(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamideNom IUPAC

C27H30F6N2O2Formule chimique

528.5 g/molMasse molaire

Dutasteride; 164656-23-9; Avodart; Avolve; GG-745; Duastride; GI-198745; GI 198745; GG 745; Dutasterida; DTXSID8046452; (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide; O0J6XJN02I; NSC-740477; (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide; alpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide; NSC-759880; DTXCID6026452; CHEBI:521033; JALYN COMPONENT DUTASTERIDE; N-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide; (1S,2R,7R,10S,11S,14S,15S)-N-[2,5-bis(trifluoromethyl)phenyl]-2,15-dimethyl-5-oxo-6-azatetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-3-ene-14-carboxamide; GG745; dutasteridum; N-(2,5-bis(trifluoromethyl)phenyl)-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide; (1S,2R,7R,10S,11S,14S,15S)-N-(2,5-bis(trifluoromethyl)phenyl)-2,15-dimethyl-5-oxo-6-azatetracyclo(8.7.0.0^(2,7).0^(11,15))heptadec-3-ene-14-carboxamide; (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-(2,5-bis(trifluoromethyl)phenyl)-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno(5,4-f)quinoline-1-carboxamide; 745, GG; RefChem:57229; G04CB02; 17beta-N-(2,5-bis(trifluoromethyl))phenyl-carbamoyl-4-aza-5alpha-androst-1-en-3-one; Avolve,(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide; Duagen; C27H30F6N2O2; MFCD00937869; 1H-Indeno[5,4-f]quinoline-7-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-; (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(2,5-Bis(trifluoromethyl)phenyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide; CHEMBL1200969; (1S,3aS,3bS,5aR,9aR,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide; Dutasteride [USAN]; (5alpha,17beta)-N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4- Aza -androst-1-ene-17-carboxamide; Avodart (TN); UNII-O0J6XJN02I; Dutasterid; Avidart; Duprost; GI198745; Dutasteride [USAN:INN:BAN]; Avidart;; Avodart;; Dutagen;; Dutasteride CRS; Avolve;; Duagen;; Dutas;; NCGC00164571-01; (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-Bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide; 1H-Indeno(5,4-f)quinoline-7-carboxamide, N-(2,5-bis(trifluoromethyl)phenyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-; GI-198745X; Dutasteride (Standard); DUTASTERIDE [MI]; DUTASTERIDE [INN]; DUTASTERIDE [JAN]; DUTASTERIDE [VANDF]; SCHEMBL5903; DUTASTERIDE [MART.]; DUTASTERIDE [USP-RS]; DUTASTERIDE [WHO-DD]; Dutasteride (JAN/USP/INN); GTPL7457; orb1308434; Dutasteride - Bio-X trade mark; SCHEMBL29454739; Dutasteride, >=98% (HPLC); DUTASTERIDE [ORANGE BOOK]; DUTASTERIDE [EP MONOGRAPH]; GLXC-06659; DUTASTERIDE [USP MONOGRAPH]; EX-A1952; MSK15349; Tox21_112199; BDBM50340481; EBC-11281; HY-13613R; NSC740477; s1202; AKOS015920136; AKOS015924431; Dutasteride for system suitability CRS; MSK15349-100A; CCG-269904; CS-1542; DB01126; FD22629; GS-3565; MSK15349-1000A; NSC 740477; NSC 759880; (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-1H,2H,4aH,4bH,5H,6H,6aH,7H,8H,9H,9aH,9bH,10H,11H,11aH-indeno[5,4-f]quinoline-7-carboxamide; BD164398; HY-13613; CAS-164656-23-9; D5973; D8276; D03820; Dutasteride Solution in Acetonitrile, 100ug/mL; EN300-124223; AB01274774-01; AB01274774_02; Dutasteride Solution in Acetonitrile, 1000ug/mL; F079399; Q424760; BRD-K30373883-001-02-8; Z1558504346; Dutasteride, European Pharmacopoeia (EP) Reference Standard; Dutasteride, United States Pharmacopeia (USP) Reference Standard; Dutasteride for system suitability, European Pharmacopoeia (EP) Reference Standard; (5.ALPHA.,17.BETA.)-N-(2,5-BIS(TRIFLUOROMETHYL)PHENYL)-3-OXO-4-AZAANDROST-1-ENE-17-CARBOXAMIDE; (5.alpha.,5 bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-1-ene-17-carboxamide;dutasteride;Avodart;; (5|_,17|_)-N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4- Aza -androst-1-ene-17-carboxamide; (5alpha,17beta)-N-{2,5-bis(trifluoromethyl)-phenyl}-3-oxo-4-azaandrost-1-ene-17-carboxamide; .ALPHA.,.ALPHA.,.ALPHA.,.ALPHA.',.ALPHA.',.ALPHA.'-HEXAFLUORO-3-OXO-4-AZA-5.ALPHA.-ANDROST-1-ENE-17.BETA.-CARBOXY-2',5'-XYLIDIDESynonymes